Targeting the Amino Acid Transporter SLC7A5 for Pulmonary Fibrosis (ATS 2024) - Feb 20, 2024 - Abstract #A6648; Pres time: May 21, 2024; 03:51 PM - 04:03 PM; Location: San Diego Convention Center, Room 7A-B (Upper Level); "The preclinical efficacy of JPH203 was evaluated in murine bleomycin treatment model of pulmonary fibrosis. In summary, our results have revealed a novel molecular and metabolic pathway(s) modulating fibrosis resolution and would be a promising cell selective therapy for IPF targeting cellular metabolism. Research Funding: NHLBI (R56HL158549 and R01HL167732 for M. C)"
Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Interstitial Lung Disease • Pulmonary Disease • Respiratory Diseases • MYC • SLC7A5 • TGFB1
|
|
M. Choudhury1; K. J. Schaefbauer1; A. H. Limper2
|